| 000 -LEADER |
|---|
| fixed length control field |
00652nam a22002177a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
IN-MiVU |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20220718121617.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
ta |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
220718s2011 xxkado|gr|||| 001 0 eng | |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780443072321 |
| Qualifying information |
pbk |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
MAIN |
| Language of cataloging |
eng |
| Transcribing agency |
IN-MiVU |
| 082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Edition number |
21 |
| Classification number |
615.19 |
| Item number |
WAT/P |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Watson, David G. |
| Relator term |
editor |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Pharmaceutical Chemistry / |
| Statement of responsibility, etc. |
edited by David G Watson. |
| 260 3# - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
United Kingdom: |
| Name of publisher, distributor, etc. |
Churchill Livingstone, |
| Date of publication, distribution, etc. |
2011. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
641p.: |
| Other physical details |
ill., charts, photographs; |
| Dimensions |
22cm. |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Project- Book(CTDS59) |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
includes references |
| 653 00 - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
Grug-Biomolecule interaction |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Koha item type |
Text Book |
